Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.71)
# 706
Out of 5,172 analysts
483
Total ratings
40.16%
Success rate
9.85%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $37 → $52 | $22.32 | +132.97% | 10 | Mar 20, 2026 | |
| LFWD Lifeward | Maintains: Buy | $4.5 → $10 | $6.74 | +48.37% | 9 | Mar 19, 2026 | |
| INAB IN8bio | Reiterates: Buy | $6 | $2.00 | +200.00% | 16 | Mar 13, 2026 | |
| ALXO ALX Oncology Holdings | Reiterates: Buy | $4 | $2.18 | +83.49% | 16 | Mar 10, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $47 → $130 | $77.76 | +67.18% | 9 | Mar 9, 2026 | |
| EVAX Evaxion | Reiterates: Buy | $16 | $3.91 | +309.21% | 15 | Mar 9, 2026 | |
| VCEL Vericel | Maintains: Buy | $60 → $64 | $31.41 | +103.76% | 19 | Feb 27, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $34.64 | +73.21% | 29 | Feb 25, 2026 | |
| ECOR electroCore | Maintains: Buy | $25 → $18 | $6.25 | +188.00% | 14 | Jan 26, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $102 → $130 | $88.51 | +46.88% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.07 | +230.76% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.09 | +91.39% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.54 | - | 17 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $1.47 | +376.19% | 11 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.96 | +170.27% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $14.06 | +220.06% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $16.96 | +112.26% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.35 | +751.06% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $94.77 | +63.55% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $106.04 | -11.35% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $3.28 | +174.39% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $12.04 | +165.78% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $7.26 | +79.06% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.28 | +16.82% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $3.17 | +236,493.06% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.17 | +327.35% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.73 | +226.89% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.94 | +219.15% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.62 | +1,688.62% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.16 | +594.44% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.78 | +283.19% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.04 | +243.14% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.85 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.00 | +200.00% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.54 | +127.27% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $3.61 | +426.32% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.35 | +658.62% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.98 | +1,990.30% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.12 | +166.99% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.58 | +3,362.60% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.03 | +28.02% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.22 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.60 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.22 | +1,949.18% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.63 | +37.74% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.24 | +3,603.70% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.17 | +11,762.40% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.10 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $13.33 | -54.99% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.17 | +1,182.05% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.53 | +496.75% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.37 | -23.20% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.88 | +1,592,619.00% | 1 | Mar 5, 2020 |
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $22.32
Upside: +132.97%
Lifeward
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $6.74
Upside: +48.37%
IN8bio
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $2.00
Upside: +200.00%
ALX Oncology Holdings
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $2.18
Upside: +83.49%
Dianthus Therapeutics
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $77.76
Upside: +67.18%
Evaxion
Mar 9, 2026
Reiterates: Buy
Price Target: $16
Current: $3.91
Upside: +309.21%
Vericel
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $31.41
Upside: +103.76%
Corcept Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $34.64
Upside: +73.21%
electroCore
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.25
Upside: +188.00%
Mirum Pharmaceuticals
Jan 26, 2026
Maintains: Buy
Price Target: $102 → $130
Current: $88.51
Upside: +46.88%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $9.07
Upside: +230.76%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.09
Upside: +91.39%
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.54
Upside: -
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.47
Upside: +376.19%
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.96
Upside: +170.27%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $14.06
Upside: +220.06%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $16.96
Upside: +112.26%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.35
Upside: +751.06%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $94.77
Upside: +63.55%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $106.04
Upside: -11.35%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.28
Upside: +174.39%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $12.04
Upside: +165.78%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $7.26
Upside: +79.06%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.28
Upside: +16.82%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $3.17
Upside: +236,493.06%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.17
Upside: +327.35%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.73
Upside: +226.89%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.94
Upside: +219.15%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.62
Upside: +1,688.62%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.16
Upside: +594.44%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.78
Upside: +283.19%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $2.04
Upside: +243.14%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.85
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.00
Upside: +200.00%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.54
Upside: +127.27%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $3.61
Upside: +426.32%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $4.35
Upside: +658.62%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.98
Upside: +1,990.30%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $4.12
Upside: +166.99%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.58
Upside: +3,362.60%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $7.03
Upside: +28.02%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.22
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.60
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.22
Upside: +1,949.18%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.63
Upside: +37.74%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.24
Upside: +3,603.70%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.17
Upside: +11,762.40%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $22.10
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $13.33
Upside: -54.99%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.17
Upside: +1,182.05%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.53
Upside: +496.75%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.37
Upside: -23.20%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.88
Upside: +1,592,619.00%